Cargando…

Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology

Parkinson’s disease (PD) is the second most common neurodegenerative disorder characterized by the accumulation of protein aggregates (namely Lewy bodies) in dopaminergic neurons in the substantia nigra region of the brain. Alpha-synuclein (α-syn) is the major component of Lewy bodies in PD patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Ning-Ning, Cai, Cui-Zan, Wu, Ming-Yue, Zhu, Qi, Su, HuanXing, Li, Min, Ren, JiaoYan, Tan, Jie-Qiong, Lu, Jia-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360163/ https://www.ncbi.nlm.nih.gov/pubmed/30745870 http://dx.doi.org/10.3389/fphar.2019.00016

Ejemplares similares

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
por: Gómez-Benito, Mónica, et al.
Publicado: (2020)

Huberine, a New Canthin-6-One Alkaloid from the Bark of Picrolemma huberi
por: López, Carlos, et al.
Publicado: (2018)

The Current State and Future of CRISPR-Cas9 gRNA Design Tools
por: Wilson, Laurence O. W., et al.
Publicado: (2018)

A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
por: Chen, Xin-Zhu, et al.
Publicado: (2022)

Fruitful Decades for Canthin-6-ones from 1952 to 2015: Biosynthesis, Chemistry, and Biological Activities
por: Dai, Jiangkun, et al.
Publicado: (2016)

Total Synthesis of Bioactive Canthine Alkaloid Cordatanine Comprising in Situ Double Oxidative Aromatization of Tetrahydrocarbazole
por: Shelar, Santosh V., et al.
Publicado: (2017)

Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators
por: Zhang, Zongying, et al.
Publicado: (2023)

Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
por: Cornet, Carles, et al.
Publicado: (2018)

Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
por: Limanaqi, Fiona, et al.
Publicado: (2019)

The Membrane Interaction of Alpha-Synuclein
por: Liu, Cencen, et al.
Publicado: (2021)

Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination
por: Hoch, Lucile, et al.
Publicado: (2022)

Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
por: Huang, Lu, et al.
Publicado: (2022)

Knockout of ABC transporters by CRISPR/Cas9 contributes to reliable and accurate transporter substrate identification for drug discovery
por: Feng, Dongyan, et al.
Publicado: (2022)

Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment
por: Li, Yang, et al.
Publicado: (2022)

Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment
por: Ercolano, Giuseppe, et al.
Publicado: (2019)

Cyclooxygenase-2 Facilitates Newcastle Disease Virus Proliferation and Is as a Target for Canthin-6-One Antiviral Activity
por: Wang, Chongyang, et al.
Publicado: (2020)

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
por: Dening, Yanina, et al.
Publicado: (2022)

Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro
por: Sala, Gessica, et al.
Publicado: (2021)

Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome
por: Ruz, Clara, et al.
Publicado: (2022)

CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson’s Disease
por: Zhu, Xiang-Xing, et al.
Publicado: (2018)

SUMOylation of Alpha-Synuclein Influences on Alpha-Synuclein Aggregation Induced by Methamphetamine
por: Zhu, Lin-nan, et al.
Publicado: (2018)

Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease
por: Das, Sabya Sachi, et al.
Publicado: (2023)

CRISPR/Cas13d-Mediated Microbial RNA Knockdown
por: Zhang, Kun, et al.
Publicado: (2020)

Hypoxic stress accelerates the propagation of pathological alpha‐synuclein and degeneration of dopaminergic neurons
por: Guo, Mengyuan, et al.
Publicado: (2022)

A Combined Human in Silico and CRISPR/Cas9-Mediated in Vivo Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation
por: Winter, Matthew J., et al.
Publicado: (2022)

A novel tool for monitoring endogenous alpha-synuclein transcription by NanoLuciferase tag insertion at the 3′end using CRISPR-Cas9 genome editing technique
por: Basu, Sambuddha, et al.
Publicado: (2017)

Novel Canthin-6-one Derivatives: Design, Synthesis, and Their Antiproliferative Activities via Inducing Apoptosis, Deoxyribonucleic Acid Damage, and Ferroptosis
por: Ding, Jinfeng, et al.
Publicado: (2023)

Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma
por: Yao, Yao, et al.
Publicado: (2022)

Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum
por: Miraglia, Fabiana, et al.
Publicado: (2020)

Direct Visualization of CHIP-Mediated Degradation of Alpha-Synuclein In Vivo: Implications for PD Therapeutics
por: Dimant, Hemi, et al.
Publicado: (2014)

The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome
por: Park, Hyo-Jin, et al.
Publicado: (2017)

Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro
por: Sala, Gessica, et al.
Publicado: (2021)

Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes
por: Scheiblich, Hannah, et al.
Publicado: (2021)

Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
por: Rcom-H'cheo-Gauthier, Alexandre N., et al.
Publicado: (2016)

Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
por: Okita, Yuho, et al.
Publicado: (2017)

Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
por: Javanshiri, Keivan, et al.
Publicado: (2022)

Alpha synuclein in hematopoiesis and immunity
por: Pei, Yu, et al.
Publicado: (2019)

Gastrointestinal Immunity and Alpha-Synuclein
por: Barbut, Denise, et al.
Publicado: (2019)

Alpha Synuclein: Neurodegeneration and Inflammation
por: Forloni, Gianluigi
Publicado: (2023)

Hepcidin-to-Ferritin Ratio Is Decreased in Astrocytes With Extracellular Alpha-Synuclein and Iron Exposure
por: Cui, Juntao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t78epnvgm24f0ipvbja01s0425